Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

But new research suggests these drugs could be doing more than helping people shed pounds. Scientists at the University of ...

Researchers compared two popular weight-loss injections and found that while both helped people lose kilos, one turned out to be more effective.